Skip to main content
logo
Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
149.97
-0.36 (-0.24%)
Aug 28, 2026, 4:00 PM EDT - Market closed

Palvella Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
2,1611,239135--
Market Cap Growth
246.11%820.07%---
Enterprise Value
1,9331,191215--
Last Close Price
149.97104.6712.00--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
9.9644.272.15--
P/TBV Ratio
9.9644.272.15--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.100.660.19-2.08-1.40
Net Debt / Equity Ratio
-1.05-1.41-1.14-0.18-0.71
Quick Ratio
21.015.117.143.112.78
Current Ratio
21.185.207.333.202.86
Return on Equity (ROE)
-46.63%-92.10%-59.37%--
Return on Assets (ROA)
-22.05%-32.65%-18.39%-61.63%-
Return on Capital Employed (ROCE)
-23.90%-80.10%-18.50%-228.80%-167.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-2.86%-3.37%-12.95%--
Buyback Yield / Dilution
-83.69%-405.46%-24.08%68.63%-
SEC Filings: 10-K · 10-Q